17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-82301/
Related
Antitrust activity in the energy and chemical sectors was steady and robust in 2020. Even though U.S...
Read More >
On January 21, 2020, New Jersey Governor Murphy enacted major revisions to the New Jersey Millville ...
Read More >
CONTROL YOUR OWN HEADLINES - In today’s high-stakes environment, in-house counsel and HR professi...
Read More >
The EEOC has long advised that asking about date of birth on job applications was a particularly bad...
Read More >
Federal construction contractors are barred from discriminating in employment on the basis of race, ...
Read More >
Soon after being elected, New Jersey’s Governor created a task force to end misclassification of in...
Read More >